Microbot Medical Inc.
MBOT
Last
$1.07
Day
+0.0%
1y
-66.2%
5y
-84.7%
52w
-67.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1132d
EMA 21
1.24
EMA 50
1.42
EMA 200
1.85
20d high
-28.4%
5y high
-88.9%
5y range
3th
Positions held
Your positionsMBOT isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.21
Stop
$0.95
Stop distance
11.2%
Target vs last
+13.1%
Fundamentals
| Market cap | $71.87M | Enterprise value | $5.38M | Trailing P/E | — | Forward P/E | -3.53 |
| PEG | 0.70 | Price / book | 1.04 | Beta | 1.05 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | -1.9% | Operating margin | -25.7% |
| Profit margin | 0.0% | ROE | -32.9% | ROA | -21.7% | Debt / equity | 0.01 |
| Current ratio | 18.56 | Free cash flow | -$14.24M | Analyst recommendation | strong_buy | Mean target | $6.33 |
| 52w high | $3.17 | 52w low | $1.05 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | — | $0.1M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | -4114.3% | — | — | — | — |
| Net income | — | -$3.7M | -$3.5M | -$3.6M | -$3.5M | -$2.6M |
| Gross margin | — | 1.9% | — | — | — | — |
| Gross profit | — | $0.0M | — | — | — | $0.0M |
| Operating income | — | -$4.3M | -$4.1M | -$3.9M | -$3.7M | -$3.0M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$13.1M | -$11.4M | -$10.7M | -$13.2M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$14.7M | -$11.6M | -$10.1M | -$13.4M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-06 · Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
2026-09-25 · Microbot Medical® Highlights Growth Strategy
2026-08-11 · Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates
2026-08-11 · Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter
Price (daily)
Full chart · RSI · MACD · patternsMBOT · daily-22.5% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin